From: Re-irradiation in lung disease by SBRT: a retrospective, single institutional study
Number | Percent | |
---|---|---|
Total number of patients | 22 | |
Males | 15 | 68 |
Females | 7 | 32 |
Primitive lung cancer | 13 | 59 |
NSCLC | 12 | 54 |
SCLC | 1 | 4 |
PET Positive, No histological report | 2 | 9 |
METASTASIS | 7 | 32 |
Colon Cancer | 2 | 10 |
Rectal Cancer | 2 | 10 |
Breast Cancer | 1 | 4 |
Carcinoma of the Uterus | 1 | 4 |
Oropharyngeal Cancer | 1 | 4 |
Histology | ||
Adenocacinoma | 13 | 59 |
Squamous Carcinoma | 6 | 27 |
SCLC | 1 | 5 |
PET Positive, No histological report | 2 | 9 |
Performace status | ||
0 | 12 | 55 |
1 | 9 | 41 |
2 | 1 | 4 |
Status of patients | ||
Patients with only one site of disease | 4 | 15 |
Patients with others site of disease, but stable | 23 | 85 |
Chemotherapy after re-irradiation | ||
Yes | 8 | 30 |
No | 19 | 70 |
Diagnosis of recurrence disease | ||
PET-CT 18FDG | 19 | 70 |
TBCT | 8 | 30 |
Histological Exam | 0 | 0 |
Localization of lesions | ||
Peripheral | 23 | 85 |
Central | 4 | 15 |